Nevertheless, GnRH-antagonist can reduce but does not completely prevent the occurrence of early LH peaks, and women with PCOS with elevated basal LH levels generally have a higher incidence of early LH elevation (LH ≥ 10 U/L) during GnRH-antagonist protocol. Here, PLOD1 is linked to polycystic ovary syndrome.